Markets and investing
bioMérieux Q3 organic sales top forecasts as U.S. outbreak boosts test demand
The French diagnostics group reported 8.1% organic sales growth in the third quarter, driven in part by demand for gastrointestinal tests during a Cyclospora outbreak. It kept its 2026 outlook unchanged.